Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Nova Cannabis Inc Com
YSSCF
Consumer Cyclical
Healthcare
Drug Manufacturers - Major
Cannabis
YSS Corp is a retailer and trusted destination for adult-use cannabis in Canada, focused on driving near-term growth while building long-term shareholder value. The company has built a strategic portfolio of Licensed Retail Stores across Alberta and in Saskatchewan and intends to expand into Ontario as well as other Canadian markets. Management is focused on strategic opportunities within the...
cannabis sector to drive shareholder value and its retail experience is built on five fundamental pillar
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (GREY:YSSCF)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(4)
•••
renegadesled
X
View Profile
View Bullboard History
Comment by
renegadesled
on Feb 21, 2021 2:32pm
RE:So when roll back and name change
5 mars
(4)
•••
Kicker99
X
View Profile
View Bullboard History
Post by
Kicker99
on Feb 20, 2021 2:17pm
So when roll back and name change
Anyone know? Thx
Voyageur Signs Letter of Intent with Large Multinational Pharmaceutical Company
posted Dec 22, 2024 9:00am by
Voyageur Pharmaceuticals Ltd
-
|
Voyageur is securing supply chains in North America for barium, iodine and fullerene drug development and is aiming to gain efficiencies in production of contrast media products. The company anticipates this LOI will expand Voyageur’s project portfolio and diversify the Company’s product mix. The global contrast media market is valued at $6.3 billion with GE HealthCare projecting it will double over the next decade. ...read more
(5)
•••
avenueman
X
View Profile
View Bullboard History
Comment by
avenueman
on Feb 10, 2021 10:13pm
RE:Why buy YSS?
simple that what the shares were valued for the purpose of the deal, but investors think the "new" YSS is worth more than .16c and it is hard to argue against that view. We will be one of
...more
(5)
•••
PatrickNeil
X
View Profile
View Bullboard History
Post by
PatrickNeil
on Jan 26, 2021 10:00am
Why buy YSS?
YSS shares are valued at $0.16 per share when the reverse merger happens, why are people buying the shares at a higher value? What am I missing?
(50)
•••
lithiums
X
View Profile
View Bullboard History
Post by
lithiums
on Jan 20, 2021 8:46am
Resume
2021-01-20 08:38 ET - Resume Trading YSS Corp. will resume at the open on Jan. 20, 2021, an announcement having been made.
(2)
•••
Gasman2010
X
View Profile
View Bullboard History
Post by
Gasman2010
on Jan 18, 2021 6:18pm
News
Thank you for clarifying that..much appreciated.
(5)
•••
PatrickNeil
X
View Profile
View Bullboard History
Comment by
PatrickNeil
on Jan 18, 2021 5:56pm
RE:News
No. It seems a bit complicated, but it's Alcanna's way of entering the public domain without an initial IPO. Our shares are being bumped to $0.16 and a consolidation, or reverse split of 18
...more
(2)
•••
Gasman2010
X
View Profile
View Bullboard History
Post by
Gasman2010
on Jan 18, 2021 3:32pm
News
Does this mean our shares are sold at .16,,,?
(9)
•••
Jonathan430
X
View Profile
View Bullboard History
Post by
Jonathan430
on Oct 21, 2020 7:59pm
Easy 20 cts soon.
Book value is 20 cts per share. Whoever buys now get 8 cts per share easily soon.
(5)
•••
PatrickNeil
X
View Profile
View Bullboard History
Comment by
PatrickNeil
on Oct 20, 2020 6:21pm
RE:No debt 4 million in Cash
The company needs to either take out a loan and accelerate some growth, start offering dividends, or start buying back stock to attract bigger investors. Until then I don't see the stock rising
...more
(2)
•••
Gasman2010
X
View Profile
View Bullboard History
Post by
Gasman2010
on Oct 20, 2020 8:41am
Very undervalued
Your right Jonathan .yss is very undervalued
(9)
•••
Jonathan430
X
View Profile
View Bullboard History
Post by
Jonathan430
on Oct 18, 2020 5:47pm
No debt 4 million in Cash
17 stores generating revenue. Very undervalued. Great time to accumulate before the next earnings report. I also see insider buying and shorts covering their position. Perhaps ready for a run.
(6)
•••
Brandonrr
X
View Profile
View Bullboard History
Post by
Brandonrr
on Aug 12, 2020 3:53pm
YSS LOOKING GOOD
YSS remains on target to exit 2020 with positive run-rate corporate EBITDA1 . This goal would be accelerated if the Company maintains a consistent pace of same-store growth for the remainder of 2020
...more
(339)
•••
Newguyrook
X
View Profile
View Bullboard History
Post by
Newguyrook
on Jun 05, 2020 12:39pm
Ok I’m back in
Not sure why it's this low, financials look good, company looks solid. Worth over double today's price. GL all
(74)
•••
Itdontmatter
X
View Profile
View Bullboard History
Post by
Itdontmatter
on Apr 06, 2020 1:09pm
re: .06 = .01 Lol
Very True !!!
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Introducing the NEW DealRoom: Your Gateway to Capital-Raising Investments